Uniqure Stock

Uniqure EBIT Margin

The EBIT Margin (Operating Margin) of Uniqure (QURE) as of Aug 6, 2026 is -921.31 %. In the previous year, EBIT Margin (Operating Margin) was -718.32 % — a change of 28.26% (lower).

EBIT Margin

-921.31 %

YoY

28.26%

Last updated:

EBIT Margin (Operating Margin) of Uniqure is 2026 -921.31 % . EBIT Margin (Operating Margin) of Uniqure was 2025 -718.32 % . It decreases by 28.26% lower compared to the previous year.

For Uniqure, the operating (EBIT) margin of -921.3% is down versus 59.5% a few years ago.

Access this data via the Eulerpool API

Uniqure Stock analysis

What does Uniqure do? Uniqure NV is a Dutch biotechnology company specializing in the development of gene therapies for rare diseases. The company was founded in 1999 and is headquartered in Amsterdam. Uniqure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Uniqure stock

EBIT Margin (Operating Margin) of Uniqure is -921.31 % in 2026.

EBIT Margin (Operating Margin) of Uniqure changed from -718.32 % to -921.31 %, representing a 28.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Uniqure since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Uniqure with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

Margins — Uniqure

All Key Metrics — Uniqure